Pinsent Masons advises the UK government on purchase of further 60m doses of Covid-19 vaccines
10 May 2021 | 09:36 am |
Multinational law firm Pinsent Masons has successfully advised the UK government on an agreement to purchase an additional 60m doses of the Pfizer BioNTech Covid-19 vaccine for the autumn revaccination programme.
The team at Pinsent Masons was led by Life Sciences transactions partner Allistair Booth and included Andy Cornforth, Niki Ruprai, Robert Sherville-Payne and Aaron Hope.
Commenting on the agreement, Allistair Booth, lead partner at Pinsent Masons said:
"This is an important agreement. Access to 60m doses of that vaccine in time for an autumn revaccination programme will hopefully play a key role in protecting the NHS and the most vulnerable people of the UK.
"We are proud to have worked with the UK government on securing this agreement for such an important vaccine at such a crucial time".
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons achieves highest number of Legal 500 UK rankings
Multinational law firm Pinsent Masons has once again topped the Legal 500 UK rankings, securing both the highest number of overall rankings and the most Tier One rankings.
Pinsent Masons advises EDF power solutions on Five Estuaries Offshore Wind Farm acquisition
Multinational law firm Pinsent Masons has advised long-standing client EDF power solutions on its acquisition of a 33.3% interest in the Five Estuaries Offshore Wind Farm project from RWE, marking a significant addition to EDF power solutions’ UK offshore wind development portfolio.
Pinsent Masons bolsters Dublin office with new corporate tax partner James Quirke
Multinational law firm Pinsent Masons has appointed new partner James Quirke to lead its corporate tax team in Dublin.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons strengthens IP offering with new patent attorney partner Fred Nicolle in London
Multinational law firm Pinsent Masons has appointed Fred Nicolle as a partner in its Intellectual Property (IP) team in London, strengthening the firm's European patents and life sciences offering.
Pinsent Masons advises Horizon 3 Healthcare on investment in Xeltis
Multinational law firm Pinsent Masons has advised Horizon 3 Healthcare as lead investor in an additional €20.5 million funding round for Xeltis, a clinical-stage medtech company developing transformative implantable medical devices.
Pinsent Masons elects John Maciver as Senior Partner
Multinational law firm Pinsent Masons has elected John Maciver as Senior Partner.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]